Neural Circulatory Control and SUDEP Risk. | MicrobiomeTrials← Back to trialsNCT02813980
Neural Circulatory Control and SUDEP Risk.
RecruitingOBSERVATIONAL
Trial Details
Start: 2016-06Est. Completion: 2031-12
Enrollment target: 39 participants Locations- Mayo Clinic, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Parkinson's Disease
This multicenter, randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy of intravenous …
Birmingham, United StatesEst. completion Nov 27, 2019
Drug Resistant EpilepsyMedically Refractory EpilepsyRefractory Epilepsy
Ketamine is a medication that came into clinical practice in the 1960's. Ketamine is used as an anesthetic and to provid…
New York, United StatesCompleted Jun 8, 2026